Richard Marlink

Dr. Richard Marlink has served at Rutgers University in New Brunswick, NJ since 2016 as the Director of the Rutgers Global Health Institute and the Henry Rutgers Professor of Global Health. A medical oncologist by training, he has extensive experience in epidemic response and capacity building, having worked to establish large-scale HIV/AIDS research, training, and clinical care programs in the U.S. and abroad. This work included helping establish the first AIDS clinic in Boston, serving as the principal investigator for “The Tshepo Study,” the first large-scale antiretroviral treatment study in southern Africa, and serving as Scientific Director and Vice President for Implementation at the Elizabeth Glaser Pediatric AIDS Foundation. More recently, Dr. Marlink’s work in NJ has focused on the COVID-19 pandemic. He serves on the Newark Reopening and Recovery Strikeforce and helped develop the city’s initial COVID-19 testing plan, while also spearheading an initiative to support the safe reopening of small businesses in low-income and minority communities and to better prepare those communities for future public health threats. Dr. Marlink has authored or co-authored 147 peer-reviewed articles, numerous scientific articles and chapters, and the textbook, Global AIDS Crisis: A Reference Handbook. He also co-edited the book, AIDS in Africa, served as chief editor for two special supplements to the journal AIDS and served as executive editor of the 320-author, three-volume textbook, From the Ground Up Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings. Dr. Marlink completed a hematology/oncology fellowship at the Beth Israel Deaconess Medical Center at Harvard Medical School. He received his medical degree from the University of New Mexico and received his bachelor’s degree from Brown University.